News and Resources

Personalized Medicine Coalition Announces Gina Ross Murdoch as Next President and CEO

The Personalized Medicine Coalition (PMC), a 501(c)3-designated nonprofit organization supported by more than 200 businesses, patient advocacy groups, and care delivery institutions, is pleased to announce Gina Ross Murdoch, MBA, as the Coalition’s next President and CEO.

Ms. Murdoch is a respected leader known for her expertise partnering with biotech, pharmaceutical, and healthcare organizations to align strategy, policy, and partnerships with high impact for both patients and markets. Known for a collaborative, data-driven leadership style, she has served as President and Chief Executive of the Multiple Sclerosis Association of America and Deputy Executive Director of the Leukemia & Lymphoma Society (now Blood Cancer United), in addition to key roles at the American Diabetes Association, the MS Coalition, the National Multiple Sclerosis Society, and the American Cancer Society.

“As precision approaches continue to transform prevention, diagnosis, and treatment worldwide,” she said, “PMC has a unique opportunity to expand its reach, influence, and global partnerships.”
Among Ms. Murdoch’s top priorities in her new role:
  • Deepening cross-sector and international collaboration to accelerate innovation and evidence development
  • Advancing patient-centered, evidence-based policy that supports scalable and equitable adoption of personalized medicine
  • Augmenting the patient voice in promoting access to and knowledge of precision medicine advances
  • Expanding PMC’s national and global footprint, strengthening connections across regions and health systems
  • Working with PMC’s current and new members to advance the Coalition’s mission and priorities
“I look forward to building on the Coalition’s strong foundation and expanding PMC’s position as a global connector and catalyst for the future of personalized medicine,” says Ms. Murdoch. “This is our moment.”

###

About personalized medicine:
Personalized medicine is an evolving field in which physicians use diagnostic tests and individual details about a person’s health to determine which medical treatments will work best for each patient, or use medical interventions to alter molecular mechanisms that impact health. By combining data from diagnostic tests with an individual’s medical history, circumstances, and values, health care providers can develop targeted prevention and treatment plans with their patients.

About the Personalized Medicine Coalition:
The Personalized Medicine Coalition, a 501(c)3-designated nonprofit organization comprised of 13 distinct stakeholder groups within health care, promotes the understanding and adoption of personalized medicine concepts, services, and products to benefit patients and health systems. PMC provides a forum for achieving consensus and informing policies that support personalized medicine. For more information about PMC, including membership details, please visit www.personalizedmedicinecoalition.org.

###

Contact:
Gina Ross Murdoch, MBA – President & CEO
gmurdoch@personalizedmedicinecoalition.org
Phone: 202-589-1770

About the Personalized Medicine Coalition:
The Personalized Medicine Coalition, a 501(c)3 organization comprised of 13 distinct stakeholder groups within health care, promotes the understanding and adoption of personalized medicine concepts, services, and products to benefit patients and health systems.

SHARE POST

Twitter Linkedin Facebook